Hidden muscle loss may affect ovarian cancer treatment
NCT ID NCT05415527
First seen Feb 01, 2026 · Last updated Jun 12, 2026 · Updated 22 times
Summary
This study checks for muscle loss (sarcopenia) in 25 women with advanced ovarian cancer who cannot have surgery right away. Researchers use CT scans to see how common muscle loss is before and during chemotherapy. The goal is to learn if muscle loss affects treatment timing and outcomes, helping doctors plan better care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Bergonié
Bordeaux, France
Conditions
Explore the condition pages connected to this study.